Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 14, 2023

SELL
$62.39 - $113.8 $25.3 Million - $46.2 Million
-405,648 Reduced 74.77%
136,895 $15.6 Million
Q3 2022

Nov 14, 2022

SELL
$58.92 - $84.67 $88,380 - $127,005
-1,500 Reduced 0.28%
542,543 $33.6 Million
Q2 2022

Aug 16, 2022

SELL
$79.4 - $116.36 $62,884 - $92,157
-792 Reduced 0.15%
544,043 $43.4 Million
Q1 2022

May 16, 2022

SELL
$86.42 - $109.81 $335,309 - $426,062
-3,880 Reduced 0.71%
544,835 $57.3 Million
Q4 2021

Feb 15, 2022

BUY
$98.56 - $119.91 $770,739 - $937,696
7,820 Added 1.45%
548,715 $59.1 Million
Q3 2021

Nov 16, 2021

SELL
$91.91 - $110.37 $540,430 - $648,975
-5,880 Reduced 1.08%
540,895 $59.3 Million
Q1 2021

May 17, 2021

BUY
$71.83 - $95.48 $7.89 Million - $10.5 Million
109,800 Added 25.13%
546,775 $50.3 Million
Q4 2020

Feb 16, 2021

BUY
$67.0 - $84.39 $637,170 - $802,548
9,510 Added 2.22%
436,975 $32 Million
Q3 2020

Nov 16, 2020

BUY
$55.23 - $79.93 $6.14 Million - $8.88 Million
111,140 Added 35.13%
427,465 $33.2 Million
Q2 2020

Aug 17, 2020

SELL
$30.2 - $56.98 $5.75 Billion - $10.9 Billion
-190,462,055 Reduced 99.83%
316,325 $17.6 Million
Q2 2020

Aug 14, 2020

BUY
$30.2 - $56.98 $5.76 Billion - $10.9 Billion
190,778,380 New
190,778,380 $17.6 Million

Others Institutions Holding HZNP

About Horizon Therapeutics Public Ltd Co


  • Ticker HZNP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 230,384,000
  • Description
  • Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...
More about HZNP
Track This Portfolio

Track Kopp Family Office, LLC Portfolio

Follow Kopp Family Office, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Kopp Family Office, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kopp Family Office, LLC with notifications on news.